CROSSJECT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.01 EUR | -5.63% |
|
-1.47% | -59.56% |
| Apr. 03 | CROSSJECT : Patience is a virtue… hopefully | AL |
| Apr. 02 | Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 110
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Needle-free Injection System
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +4.61% |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +4.61% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 01-08-07 | |
Olivier Giré
PRN | Corporate Officer/Principal | - | 15-12-31 |
| Corporate Officer/Principal | - | 12-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Teper
BRD | Director/Board Member | 64 | 23-06-06 |
Eric Nemeth
BRD | Director/Board Member | 65 | - |
Philippe Monnot
CHM | Chairman | 65 | - |
Yannick Plétan
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 36,763,256 | 22,491,997 ( 61.18 %) | 0 | 61.18 % |
| Stock B | 0 | 1,655,925 | 0 | 0 |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
CROSSJECT 0.29% | 106,603 | 0.29% | 362,663 $ |
Company contact information
Crossject SA
6, rue Pauline Kergomard ZAC Parc Mazen Sully
21000, Dijon
+33 3 80 54 98 50
http://www.crossject.com
Sector
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.01
EUR
Average target price
5
EUR
Spread / Average Target
+148.76%
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCJ Stock
- Company Crossject
